Patent Assignment
Reel/Frame 016926/0784
Address Change
Recorded: 2005-12-22
Pages: 8
Assignor
DAIICHI ASUBIO PHARMA CO., LTD.
Executed: 2005-10-11
Assignee
DAIICHI ASUBIO PHARMA CO., LTD.
9-11, AKASAKA 2-CHOME, MINATO-KU, TOKYO, JAPAN
Covered Properties
(82)
An H-Anp Peptide, Pharmaceutical Composition and Method of Use
Patent:
5,354,900 →
Application:
06/685,151 →
Extended Range Regulated Power Supply
Patent:
4,713,554 →
Application:
06/851,227 →
Pharmaceutical Composition for the Treatment of Infantile Autism
Patent:
4,778,794 →
Application:
06/870,495 →
Novel Host E. Coli and Use Thereof
Patent:
4,874,697 →
Application:
06/947,398 →
Peptide and Gene Coding for Same
Patent:
5,118,615 →
Application:
07/023,818 →
Use of a 97 Amino Acid Leader Sequence from the E. Coli B-Galactosidase Gene for the Production of -Hanp and Hptc as Fusion Protein
Patent:
4,987,070 →
Application:
07/163,548 →
Pharmaceutical Composition and Method for the Treatment of Infantile Autism
Patent:
4,920,122 →
Application:
07/210,312 →
Recombinant C-Terminal Alpha-Amidating Enzyme
Patent:
6,262,232 →
Application:
07/219,375 →
KEX2 Endoprotease Without a C-Terminal Hydrophobic Region
Patent:
5,162,220 →
Application:
07/304,211 →
Process for the Preparation of 4-Acyloxy-2-Azetidinone Derivatives
Patent:
5,026,844 →
Application:
07/421,331 →
Benzoxazepine Derivative
Patent:
5,071,845 →
Application:
07/454,273 →
Process for Preparing Optically Active Tetrahydro-2-Furoic Acid
Patent:
4,985,575 →
Application:
07/475,801 →
Penem Compounds and Use Thereof
Patent:
4,997,829 →
Application:
07/496,145 →
Recombinant C-Terminal Alpha-Amidating Enzyme
Patent:
6,245,887 →
Application:
07/509,583 →
Porcine Cnp Gene and Precursor Protein
Patent:
6,020,168 →
Application:
07/728,220 →
Rat Cnp Complementary Dna and Precursor Protein
Patent:
5,973,134 →
Application:
07/757,606 →
Human Cnp Gene and Precursor Protein
Patent:
6,034,231 →
Application:
07/765,830 →
Cnp Analog Peptides and Their Use
Patent:
5,434,133 →
Application:
07/828,450 →
Dna Encoding a KEX2 Endoprotease Without a C-Terminal Hydrophobic Region
Patent:
5,234,830 →
Application:
07/916,627 →
Antibacterial Penem Esters Derivatives
Patent:
5,830,889 →
Application:
07/971,829 →
Fluid Delivery System
Patent:
5,445,631 →
Application:
08/192,282 →
Oxidized Phospholipid Degrading Enzyme and Gene Thereof
Patent:
5,849,557 →
Application:
08/283,917 →
Process for Producing Peptides in E.Coli
Patent:
5,670,340 →
Application:
08/352,179 →
Suppressant of Corneal Subepithelial Clouding
Patent:
5,585,354 →
Application:
08/404,150 →
Method for Controlling Gene Expression
Patent:
5,622,840 →
Application:
08/456,923 →
Antibacterial Penem Esters Derivatives
Patent:
5,885,981 →
Application:
08/470,944 →
Antibodies Specific for Megakaryocyte Differentiation Factor
Patent:
5,831,030 →
Application:
08/472,659 →
Dna Encoding Megakaryocyte Differentiation Factor
Patent:
5,874,253 →
Application:
08/474,661 →
Copper Cataylzed Process for Producing 4-Substituted Azetidinone Derivatives
Patent:
5,808,055 →
Application:
08/498,499 →
Process for Production of Protein
Patent:
6,037,145 →
Application:
08/523,373 →
Method of Desilylating Silylether Compounds
Patent:
5,821,362 →
Application:
08/579,453 →
Megakaryocyte Differentiation Factor
Patent:
5,972,886 →
Application:
08/611,977 →
Imidazolidine Derivative and Use Thereof
Patent:
5,691,335 →
Application:
08/615,277 →
Method for Treating Spinocerebellar Degeneration
Patent:
5,753,656 →
Application:
08/632,412 →
Mutant Staphylococcus Aureus V8 Proteases
Patent:
5,747,321 →
Application:
08/657,192 →
Remedy for Prurigo
Patent:
5,972,365 →
Application:
08/709,093 →
Medicament for the Alleviation or Treatment of Symptom Derived from Ischemic Disease and Compound Useful Therefor
Patent:
6,048,876 →
Application:
08/714,104 →
Novel Method for Animal Cell Culture
Patent:
5,976,833 →
Application:
08/716,533 →
Arylpiperidine and Arylpiperazine Derivatives and Medicament Containing the Same
Patent:
5,723,475 →
Application:
08/732,284 →
Process for Preparing 1-Substituted Pyrrole-3-Carboxylic Acid Derivatives
Patent:
5,684,161 →
Application:
08/741,911 →
Recombinant C-Terminal Alpha-Amidating Enzyme
Patent:
5,821,083 →
Application:
08/759,184 →
Process for Production of Secretory KEX2 Derivatives
Patent:
5,885,821 →
Application:
08/805,918 →
Method for Culturing Microorganisms Having Methanol Metabolic Pathway
Patent:
6,171,828 →
Application:
08/811,024 →
Method for Cleaving Chimeric Protein Using Processing Enzyme
Patent:
5,891,671 →
Application:
08/811,028 →
Cyclopropachromencarboxylic Acid Derivatives
Patent:
5,843,988 →
Application:
08/817,389 →
Enzymatic Production of a C-Terminal Alpha-Amidated Peptide or Protein
Patent:
6,602,681 →
Application:
08/845,381 →
Quinazoline Derivatives and Applications Thereof
Patent:
5,814,631 →
Application:
08/849,114 →
Production Method of Optically Active Trans-Vinylsulfide Alcohol
Patent:
6,049,009 →
Application:
08/860,563 →
Platelet Activating Factor Acetylhydrolase, and Gene Thereof
Patent:
5,880,273 →
Application:
08/886,152 →
1'S 5R, 6R-Carbapenem Derivatives and Antimicrobial Agents Comprising the Same
Patent:
6,051,569 →
Application:
08/911,937 →
Oxidized Phospholipid Degrading Enzyme and Gene Thereof
Patent:
5,880,272 →
Application:
08/961,716 →
Arylpiperidinol and Arylpiperidine Derivatives and Drugs Containing the Same
Patent:
6,455,549 →
Application:
09/043,563 →
Method for Screening Compounds Regulating the Expression of Human-Inducible Nitric Oxide Synthase
Patent:
6,203,982 →
Application:
09/068,880 →
Platelet Activating Factor Acetylhydrolase, and Gene Thereof
Patent:
6,323,017 →
Application:
09/196,222 →
Method of Production and Method of Separation of 2,4'-Dipyridyl Derivatives and Methods of Production of Benzoxazepine Derivatives and Salts Thereof
Patent:
6,096,884 →
Application:
09/230,168 →
Process of Production of 4-Substituted-3-Halogeno-1,4-Benzoxazepine Derivative and Salts Thereof
Patent:
6,114,522 →
Application:
09/254,719 →
Method for Screening Substance Inhibiting Activation of Nf-Kappa B
Patent:
6,156,516 →
Application:
09/272,706 →
1-Aryl-1,8-Naphthylidin-4-One Derivative as Type Iv Phosphodiesterase Inhibitor
Patent:
6,297,248 →
Application:
09/284,019 →
Benzoxazepine Derivatives and Their Salts and Medicaments Containing the Same
Patent:
6,187,769 →
Application:
09/306,995 →
Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same
Patent:
6,407,099 →
Application:
09/331,712 →
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Patent:
6,271,223 →
Application:
09/367,841 →
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Patent:
6,331,623 →
Application:
09/367,842 →
1-Cycloalkyl-1,8-Naphthyridin-4-One Derivative as Type Iv Phosphodiesterase Inhibitor
Patent:
6,331,548 →
Application:
09/402,142 →
Prophylactic or Therapeutic Agents for Drug-Induced Renal Injury
Patent:
6,288,067 →
Application:
09/427,550 →
Prophylactic or Therapeutic Agents for Diseases Haivng Vascular Dysfunction Associated with Insulin Resistance
Medicament for the Alleviation or Treatment of Symptom Derived from the Ischemic Disease and Compound Useful Therefor
Patent:
6,469,010 →
Application:
09/532,934 →
Nf-Kb Inhibitor Comprising an Indan Derivative as an Active Ingredient
Patent:
6,734,180 →
Application:
09/532,935 →
Aminophenoxyacetic Acid Derivatives and Pharmaceutical Composition Containing Thereof
Patent:
6,559,146 →
Application:
09/581,756 →
Method of Production and Method of Separation of 2,4'-Dipyridyl Derivatives and Methods of Production of Benzoxazepine Derivatives and Salts Thereof
Pyrimidine Derivatives and Their Salts, Useful for Making Benzoxazepine Derivatives
Patent:
6,337,397 →
Application:
09/726,481 →
Quinazoline Derivatives and Pharmaceutical Applications Therof
Patent:
6,867,214 →
Application:
09/763,213 →
Antibacterial Medicinal Compositions
Patent:
6,531,508 →
Application:
09/856,094 →
Blood Vessel Lipid Deposition-Preventive Agent Comprising Chymase-Inhibitor
Patent:
6,921,766 →
Application:
09/869,360 →
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
1-Aryl-1,8-Naphthylidin-4-One Derivative as Type Iv Phosphodiesterase Inhibitor
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Preventive or Therapeutic Drugs for Fibrosis Containing Chymase Inhibitors as the Active Ingredient
A Chymase Inhibitor for the Treatment of Eosinophilia
Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same
Patent:
6,525,199 →
Application:
10/118,045 →
Arylpiperidinol and Arylpiperidine Derivatives and Pharmaceuticals Containing the Same
Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.